June 08, 2017
A New Jersey-based generic-drug maker has filed a federal lawsuit alleging that a Florida pharmaceutical company ensnared it in frivolous business litigation over allegedly adulterated drugs and then cost it business by announcing the allegations in a worldwide media release.